KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

New York Times (NYT) Research & Development (2019 - 2025)

New York Times' Research & Development history spans 7 years, with the latest figure at $66.9 million for Q4 2025.

  • For Q4 2025, Research & Development rose 8.28% year-over-year to $66.9 million; the TTM value through Dec 2025 reached $264.3 million, up 6.51%, while the annual FY2025 figure was $264.3 million, 6.51% up from the prior year.
  • Research & Development for Q4 2025 was $66.9 million at New York Times, roughly flat from $67.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $67.0 million in Q3 2025 and bottomed at $38.9 million in Q1 2021.
  • The 5-year median for Research & Development is $57.2 million (2023), against an average of $55.3 million.
  • The largest annual shift saw Research & Development soared 33.34% in 2022 before it rose 2.76% in 2025.
  • A 5-year view of Research & Development shows it stood at $41.6 million in 2021, then surged by 33.34% to $55.5 million in 2022, then rose by 5.06% to $58.3 million in 2023, then grew by 6.01% to $61.8 million in 2024, then increased by 8.28% to $66.9 million in 2025.
  • Per Business Quant, the three most recent readings for NYT's Research & Development are $66.9 million (Q4 2025), $67.0 million (Q3 2025), and $63.9 million (Q2 2025).